Metropolitan Life Insurance Co. NY lessened its stake in shares of Quidel Co. (NASDAQ:QDEL) by 53.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,220 shares of the company’s stock after selling 10,387 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Quidel were worth $400,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of QDEL. Macquarie Group Ltd. boosted its holdings in shares of Quidel by 12.7% in the 4th quarter. Macquarie Group Ltd. now owns 1,132,743 shares of the company’s stock valued at $49,105,000 after purchasing an additional 128,081 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Quidel by 2,374.6% in the 4th quarter. Millennium Management LLC now owns 579,709 shares of the company’s stock valued at $25,130,000 after purchasing an additional 556,283 shares in the last quarter. Cornerstone Capital Management Holdings LLC. acquired a new stake in shares of Quidel in the 4th quarter valued at $156,000. York Capital Management Global Advisors LLC boosted its holdings in shares of Quidel by 50.2% in the 4th quarter. York Capital Management Global Advisors LLC now owns 120,371 shares of the company’s stock valued at $5,218,000 after purchasing an additional 40,243 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Quidel by 10.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 857,195 shares of the company’s stock valued at $37,159,000 after purchasing an additional 83,894 shares in the last quarter. Hedge funds and other institutional investors own 93.34% of the company’s stock.

How to Become a New Pot Stock Millionaire

A number of equities research analysts have weighed in on QDEL shares. Craig Hallum assumed coverage on Quidel in a report on Monday, March 26th. They issued a “buy” rating and a $62.00 target price on the stock. BidaskClub raised Quidel from a “hold” rating to a “buy” rating in a report on Saturday, March 10th. Canaccord Genuity reissued a “buy” rating and set a $52.00 price objective (up previously from $48.00) on shares of Quidel in a report on Thursday, December 21st. CL King raised Quidel from a “neutral” rating to a “buy” rating and set a $52.00 price objective on the stock in a report on Thursday, January 4th. Finally, Piper Jaffray reissued a “buy” rating and set a $60.00 price objective on shares of Quidel in a report on Wednesday, January 24th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and three have given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $57.29.

In other Quidel news, CEO Douglas C. Bryant sold 12,000 shares of Quidel stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $44.63, for a total transaction of $535,560.00. Following the transaction, the chief executive officer now directly owns 302,843 shares of the company’s stock, valued at approximately $13,515,883.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Douglas C. Bryant sold 36,000 shares of Quidel stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $44.32, for a total value of $1,595,520.00. Following the transaction, the chief executive officer now directly owns 302,843 shares in the company, valued at $13,422,001.76. The disclosure for this sale can be found here. Insiders have sold a total of 120,000 shares of company stock worth $5,751,720 over the last ninety days. Company insiders own 22.00% of the company’s stock.

NASDAQ QDEL opened at $56.22 on Tuesday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 2.06 and a current ratio of 2.58. Quidel Co. has a twelve month low of $22.44 and a twelve month high of $56.43. The firm has a market cap of $2,079.19, a P/E ratio of -803.14, a PEG ratio of 0.92 and a beta of 0.89.

Quidel (NASDAQ:QDEL) last released its quarterly earnings data on Wednesday, February 21st. The company reported $0.56 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.70. Quidel had a negative return on equity of 3.02% and a negative net margin of 2.94%. The company had revenue of $114.90 million for the quarter, compared to the consensus estimate of $115.06 million. During the same quarter last year, the business posted $0.17 EPS. Quidel’s revenue for the quarter was up 117.6% on a year-over-year basis. analysts forecast that Quidel Co. will post 2.44 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Metropolitan Life Insurance Co. NY Sells 10,387 Shares of Quidel Co. (QDEL)” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2018/04/17/metropolitan-life-insurance-co-ny-sells-10387-shares-of-quidel-co-qdel.html.

Quidel Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Want to see what other hedge funds are holding QDEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quidel Co. (NASDAQ:QDEL).

Institutional Ownership by Quarter for Quidel (NASDAQ:QDEL)

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.